BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//132.216.98.100//NONSGML kigkonsult.se iCalcreator 2.20.4//
BEGIN:VEVENT
UID:20251022T100845EDT-76227wk0LD@132.216.98.100
DTSTAMP:20251022T140845Z
DESCRIPTION:Joignez-vous à D2R et l’Institut du cancer Rosalind et Morris G
 oodman (GCI) pour un événement en l’honneur du Mois de la sensibilisation 
 au cancer du sein et du Mois de l’histoire des femmes\, en collaboration a
 vec la Fondation du cancer du sein du Québec et l’association Audace au fé
 minin.\n\nCet événement en présentiel est ouvert à toutes et à tous. Venez
  participer à une discussion sur la manière dont l’équité\, la diversité e
 t l’inclusion\, ainsi que les thérapies à base d’ARN guidées par la génomi
 que\, travaillent de concert pour faire progresser la lutte contre le canc
 er du sein. Après les mots d’ouverture de survivantes du cancer du sein\, 
 Jennifer Fitzpatrick et Mélissa Nelson\, l’événement proposera deux panels
  dynamiques réunissant des chercheuses et chercheurs\, des étudiantes et é
 tudiants ainsi que des cliniciennes et cliniciens. La soirée se terminera 
 par une séance de réseautage autour de rafraîchissements légers.\n\nDétail
 s de l'événement\n\n\n	Titre: Cancer du sein et thérapies à base d’ARN : ex
 plorer des perspectives inclusives en recherche et en carrière\n	Date: merc
 redi 22 octobre 2025\n	L'heure: de 17 h à 20 h 30\n	Lieu: Cet événement en p
 résentiel - Bellini Building Atrium\n\n\nInscription\n\nParticipez à cette
  discussion transformative sur l’avenir de la lutte contre le cancer du se
 in. Réservez votre place avant le 19 octobre 2025 !\n\n\n	Réservez votre pl
 ace dès maintenant !\n\n\nAgenda\n\nVeuillez noter que les panels se dérou
 leront en anglais\n\n\n	\n		\n			5:00PM\n			Portes ouvertes\n		\n		\n			5:15PM\n			\n				Mot de b
 ienvenue et remarques d’ouverture par :\n\n				\n					Giovanna Sebastiani\, Directr
 ice des administrations chez D2R\n					Trina Johnson\, Directrice adjointe à l’
 Institut du cancer Rosalind et Morris Goodman (GCI)\n					Jennifer Fitzpatrick\
 , survivante du cancer du sein et professeure adjointe\, Département de gé
 nétique humaine\, Université 91ºÚÁÏÍø\n					Mélissa Nelson\, survivante du cancer
  du sein et responsable de programme à la Fondation cancer du sein du Québ
 ec\n				\n			\n		\n		\n			5:30PM\n			\n				Panel avec des professeurs et des étudiants – Découv
 rez les carrières et les opportunités de recherche en thérapeutiques ARN g
 uidées par la génomique pour lutter contre le cancer du sein de manière in
 clusive\n\n				\n					Panélistes : Alexandra Goudreau\, Yann Joly\, Alice Jason Nam
 \, Hellen Kuasne\, Laura Palma\n					Modératrice : Mariloue Daudie\n				\n			\n		\n		\n			6:3
 0PM\n			\n				Partenariat avec les patientes et la communauté – Quelles sont les 
 attentes et les besoins des personnes vivant avec le cancer du sein en mat
 ière de médecine de précision? Comment peut-on améliorer l’accès aux nouve
 lles thérapies de manière sécuritaire et efficace? \n\n				\n					Panélistes : Eliz
 e Dushime\, Mélissa Nelson\, Aldanie Rho\, Stephanie Wong \n					Modératrice : 
 Jennifer Fitzpatrick\n				\n			\n		\n		\n			7:30PM\n			Remarques de clôture et séance de ré
 seautage\n		\n	\n\n\n\n	Intervenants\n\n	Panel 1 | Découvrez les carrières et l
 es opportunités de recherche en thérapeutiques ARN guidées par la génomiqu
 e pour lutter contre le cancer du sein de manière inclusive\n\n	\n\n	\n		En sa
 voir plus\n\n		\n			Alexandra Goudreau \n\n			Alexandra Goudreau completed her Bac
 helor’s in Biomedical Science and Master’s in Human Kinetics at the Univer
 sity of Ottawa before beginning her PhD in Experimental Medicine at 91ºÚÁÏÍø
  University in 2022. Her research focuses on identifying new drug targets 
 for treatment-resistant metastatic breast cancer. Outside the lab\, she se
 rves on the Equity\, Diversity and Inclusion Advisory Committee at the Lad
 y Davis Institute. She is passionate about science communication and acces
 sibility and about making cancer research more inclusive for both scientis
 ts and patients.\n\n			Yann Joly\n\n			Yann Joly is the Director of the Centre o
 f Genomics and Policy (CGP) at 91ºÚÁÏÍø. He is a James 91ºÚÁÏÍø Pro
 fessor at the Faculty of Medicine and Health Sciences\, Department of Huma
 n Genetics. Prof. Joly is also an associate member of the Bioethics Unit a
 nd at the Law Faculty at 91ºÚÁÏÍø. He has a secondary appointment as adjunct
  professor at Yonsei University in South Korea. Prof. Joly was named advoc
 atus emeritus by the Quebec Bar in 2012 and Fellow of the Canadian Academy
  of Health Sciences in 2017.\n\n			Alice Jisoo Nam \n\n			Alice Jisoo Nam is a P
 h.D. candidate in Biochemistry at 91ºÚÁÏÍø’s Rosalind & Morris Go
 odman Cancer Institute\, where she investigates novel mechanisms of breast
  cancer progression and therapeutic resistance. One of her current project
 s focuses on the development of RNA-based therapeutics against an oncogeni
 c splice variant of the HER2 protein. Alice’s work bridges molecular biolo
 gy\, bioengineering\, and clinical collaboration to advance genomics-guide
 d precision medicine. Beyond the lab\, Alice is deeply committed to scienc
 e communication\, equity in STEM\, and trainee development.\n\n			Hellen Kuas
 ne\n\n			Dr. Kuasne is a Research Associate at the Rosalind and Morris Goodma
 n Cancer Institute at 91ºÚÁÏÍø. Her work focuses on developing pr
 eclinical models for functional precision medicine applications and drug v
 alidation. In addition to her research\, Dr. Kuasne manages the Breast Can
 cer Biobank\, led by Dr. Park\, and serves as a site cohort coordinator fo
 r the Marathon of Hope (MoH) initiative\, coordinating genomic and transcr
 iptomic sequencing of rare and metastatic breast cancer specimens.\n\n			Laur
 a Palma\n\n			Laura received her Master of Science degree in Genetic Counsell
 ing from the University of Toronto in 2005 and joined the Division of Medi
 cal Genetics at the 91ºÚÁÏÍø Health Center\, where she remains to
 day. Laura has worked for over 20 years in the field of hereditary cancer\
 , counselling patients and families in both adult and pediatric settings. 
 She is an Assistant Professor in the 91ºÚÁÏÍø Department of Human Genetics a
 nd has contributed to the development and implementation of mainstreaming 
 genetic testing for breast and ovarian cancer at her hospital institution 
 and is engaged in many aspects of the cancer genetics community both local
 ly and nationally.\n\n			Mariloue Daudier\n\n			Mariloue is the Senior EDI Advis
 or for the D2R initiative. She earned a Bachelor’s degree of Social Work f
 rom 91ºÚÁÏÍø in 2013 and a Master’s degree of Social Innovation M
 anagement from HEC Montréal in 2016. She has over ten years of experience 
 in EDI projects in many settings\, including the social economy sector\, c
 ommunity organizations\, the private and public sectors. She is regularly 
 invited as a speaker\, facilitator\, evaluator or trainer to share her exp
 ertise in EDI in different contexts.\n		\n	\n\n	\n	Panel 2 | Discover genomic-g
 uided RNA therapeutics research careers and research opportunities to figh
 t breast cancer in an inclusive way\n\n	\n\n	\n		En savoir plus\n\n		\n			Elize Dus
 hime \n\n			Elize Dushime is the Health Promotion Coordinator at the Quebec B
 reast Cancer Foundation. With a professional training in Public Health and
  Nutrition\, she coordinates initiatives for breast cancer awareness and t
 he promotion of healthy lifestyles.\n\n			Mélissa Nelson\n\n			Mélissa Nelson is
  a biochemist and nurse specializing in environmental health. She began he
 r career in endocrinology research at the CHUM Research Centre before comp
 leting a bachelor's degree in biochemistry and molecular medicine (genetic
 s option). Driven by her passion for the fight against breast cancer\, she
  continued her work in Dr. Sylvie Mader’s lab at the IRIC\, focusing on mo
 lecular targeting in breast oncology. Now in remission from HER2+ hormone-
 dependent breast cancer she uses her journey to raise awareness\, particul
 arly among Black and racialized women\, about the importance of informatio
 n\, prevention\, and proactive approaches to breast cancer.\n\n			Aldanie Rho
 \n\n			Dr. Aldanie Rho is a dedicated and accomplished medical professional. 
 She earned her medical degree in both Haiti and Canada\, graduating from U
 niversité Laval. She also holds a master's degree in public health and has
  authored numerous scientific publications in psychiatry\, clinical medici
 ne\, and public health. Passionate about music and lifelong learning\, she
  brings a well-rounded perspective to her work and community engagement. S
 ince 2024\, she has been actively involved with Audace au Féminin\, notabl
 y contributing to the Campagne Têtons Ben Drôle — a breast cancer awarenes
 s initiative aimed at promoting screening and encouraging participation in
  clinical research.\n\n			Stephanie Wong\n\n			Stephanie Wong is an assistant pr
 ofessor of surgery at 91ºÚÁÏÍø and a breast surgical oncologist at the JGH S
 egal Cancer Centre. A graduate of 91ºÚÁÏÍø and the Harvard School
  of Public Health\, she completed a breast surgical oncology fellowship at
  Dana-Farber/Brigham and Women’s Cancer Centre and Massachusetts General H
 ospital. Dr. Wong directs the High Risk Breast Clinic at the JGH Stroll Ca
 ncer Prevention Centre and in 2021 was recipient of the FRQS Chercheurs Bo
 ursiers Cliniciens award for research on Optimizing Surgical Decision Maki
 ng and Prevention Strategies for Women at Elevated Breast Cancer Risk.\n\n
 			Jennifer Fitzpatrick\n\n			Jennifer Fitzpatrick is a genetic counsellor and A
 ssistant Professor in the Department of Human Genetics. She obtained her B
 Sc in Biology from 91ºÚÁÏÍø and her MS in Human Genetics/Genetic 
 Counseling from the University of Michigan. She has worked clinically at t
 he Hospital for Sick Children\, Toronto\, the University of Maryland Medic
 al Center\, Baltimore\, the Montreal Children’s Hospital and the Jewish Ge
 neral Hospital. She is the Director of the MSc in Genetic Counselling Prog
 ram and enjoys teaching and learning with students in the Faculties of Med
 icine\, Biomedical Sciences and Law.\n		\n	\n\n
DTSTART:20251022T210000Z
DTEND:20251023T003000Z
LOCATION:CA\, Bellini Building Atrium\, 3649 Promenade Sir William Osler
SUMMARY:Événement en présentiel | Cancer du sein et thérapies à base d’ARN 
 : explorer des perspectives inclusives en recherche et en carrière
URL:/centre-montreal/fr/channels/event/evenement-en-pr
 esentiel-cancer-du-sein-et-therapies-base-darn-explorer-des-perspectives-i
 nclusives-368005
END:VEVENT
END:VCALENDAR